SHANG.FOS.PHARM.GR.H YC 1 Tangible Net Worth Ratio
SHANG.FOS.PHARM.GR.H YC 1 tangible net worth ratio. SHANG.FOS.PHARM.GR.H YC 1 (08HH) has a Tangible Net Worth Ratio of 66.0% as of March 2026. This metric is calculated by deducting intangible assets (€21.62 Billion) from net assets (€63.67 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See 08HH equity to assets ratio to measure how much of total assets are equity-financed.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of SHANG.FOS.PHARM.GR.H YC 1 (2021–2025)
Tangible net worth ratio of SHANG.FOS.PHARM.GR.H YC 1 from 2021 to 2025. This chart shows how SHANG.FOS.PHARM.GR.H YC 1's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 66.0%, reflecting net assets of €63.67 Billion with intangible assets of €21.62 Billion EUR. See working capital to net assets of SHANG.FOS.PHARM.GR.H YC 1 to evaluate short-term liquidity relative to the company's equity base.
SHANG.FOS.PHARM.GR.H YC 1 Tangible Net Worth Ratio by Year (2021–2025)
SHANG.FOS.PHARM.GR.H YC 1 tangible net worth ratio by year from 2021 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for SHANG.FOS.PHARM.GR.H YC 1 from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see SHANG.FOS.PHARM.GR.H YC 1 stock valuation.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 67.8% | €61.84 Billion | €19.94 Billion | €120.05 Billion | ▲ +0.0 pp |
| 2024 | 67.7% | €59.93 Billion | €19.34 Billion | €117.46 Billion | ▼ -1.6 pp |
| 2023 | 69.3% | €56.62 Billion | €17.38 Billion | €113.47 Billion | ▼ -1.3 pp |
| 2022 | 70.6% | €54.11 Billion | €15.93 Billion | €107.16 Billion | ▼ -1.7 pp |
| 2021 | 72.2% | €48.38 Billion | €13.43 Billion | €93.31 Billion | — |